Anionic charge sites in the kidney: Comparison of two diabetic rat models

Annals of Clinical and Laboratory Science

Volumn 29, Issue 4, 1999, Pages 286-298

  Ward Cook, Kory M ^a   Mahan, John D ^a   Frenchko, Carla E ^a   Albright, Ann ^a   Chiasera, Janelle M ^a   McAllister, Cinthia ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; GLOMERULUS BASEMENT MEMBRANE; INSULIN DEPENDENT DIABETES MELLITUS; ION CURRENT; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEINURIA; RAT; STATISTICAL ANALYSIS; STREPTOZOCIN DIABETES;

ANIMALS; ANIONS; BASEMENT MEMBRANE; BLOOD GLUCOSE; COLORING AGENTS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DISEASE MODELS, ANIMAL; GLOMERULAR MESANGIUM; GLYCOSYLATION END PRODUCTS, ADVANCED; KIDNEY FUNCTION TESTS; KIDNEY GLOMERULUS; RATS; RATS, SPRAGUE-DAWLEY; RATS, ZUCKER;

ANIMALIA; GLOMERULUS;

EID: 0032722278     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. United States Renal Service. Annual report. Am J Kidney Dis 1990;16:16-21.
2. Mogensen CE, Christensen CK, Viltingus E. The stages of diabetic renal disease with emphasis on the stage of incipient diabetic nephropathy. Diabetes 1983;32:64-78.
3. Hostetter TH. Diabetic Nephropathy. In: Brennan BNI, Rector FC, eds. The kidney, Philadelphia: W.B. Saunders 1986:1377-1402.
4. Ward KM. Renal function (microalbuminuria). Anal Chem 1995;67:383R-391R.
5. Reynold AE, Mintz DH, Muller WA, Cahill GF. Diabetes mellitus. In: Stanburg VJB, Wyangarden JB, Frederickson DS, eds. The Metabolic Basis of Inherited Disease, New York: McGraw Hill 1978;88-109.
6. Vlassara H, Brownlee M, Cerami A. Nonenzymatic glycosylation: role in pathogenesis of diabetic complications. Clin Chem 1986;32:B37-B41.
7. Viberti GC. Kecent advances in understanding-mechanisms and natural history of diabetic renal disease. Diabetes Care 1988;11:3-9.
8. Brenner BM, Hostetter TH, Humes HD. Glomerular perselectivity: barrier function based on discrimination of molecular size and charge. Am J Physiol 1978; 234:F455-F460.
9. Kanwar YS, Hascall VC, Carone FA. Proteoglycans of renal basement membranes. In: Price RG, Hudson BG, eds. Renal Basement Membranes in Health and Disease, London Academic Press 1987:115-134.
10. Wu V-Y, Wilson B, Cohen MP. Disturbances in glomerular basement membrane glycosaminoglycans in experimental diabetes. Diabetes 1987;36;679-683.
11. Templeton DE. Retention of glomerular basement membrane proteoglycans accompanying loss of anionic site staining in experimental diabetes. Lab Invest 1989;61:202-211.
12. Kanwar YS, Farquahar MG. Presence of heparin sulfate in the glomerular basement membrane. Proc Natl Acad Sci 1979;76:1303-1307.
13. Rosenzweig LJ, Kanwar Y. Removal of sulfated or nonsulfate glycosamonoglycans results in increased permeability of the glomerular basement membrane to 251-bovine serum albumin. Lab Invest 1982;47: 177-184.
14. Scott JE. Collagen-proteoglycan interactions. Localisation of proteoglycans in tendons by electron microscopy. Biochem J 1980;187:887-889.
15. Vernier RL, Sisson-Ross SP, Mauer SM. Cyto chemical studies of anionic charges in the kidney in type I diabetes mellitus. Diab Nephrop 1987;1:15-19.
16. Kobayashi S, Nagase M, Honda N, Adachl K, Ichinose N, Hishida A. Analysis of anionic charge of the glomerular basement membrane in aminonucleoside nephrosis. Kidney Intl 1989;35:1405-1408.
17. Chakrabart S, Ma N, Sima A. Reduced number of anionic sites is associated with glomerular basement membrane thickening in the diabetic 1313-rat. Diabetologia 1989;32:826-828.
18. Deckert T, Andersen AR, Christiansen JS, Andersen JK. Course of diabetic nephropathy factors related to development. Acta Endocrinol 1981;97:14-15.
19. Kanvar YS, Jakubowski ML. Unaltered anionic sites of glomerular basement membrane in am nonucleoside nephrosis. Kidney Intl 1984;25:613-618.
20. Jarrett RJ, Vibert GC, Argyropoulos A, Hill RD, Mahmud U, Murrells TJ. Microalbuminuria predicts mortality in non-insulin-dependent diabetes. Diabetic Med 1984;1:17-19.
21. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. New Engl J Med 1984;310:356-360.
22. Cooper ME, Frauman A, O'Brien RC, Seeman E, Murray R, Jerums G. Progression of proteinuria in type I and type II diabetes. Diabetic Med 1988;5:361-368.
23. Schmitz A, Vaeth M. Microalbuminuria: a major risk factor in non-insulin-dependent diabetes. A ten year follow up study of 503 patients. Diabetic Med 1988; 5:126-134.
24. Schmitz A, Gundersen H, Osterby R. Glomerular morphology by light microscopy in non-insulin-dependent diabetes mellitus: lack of glomerular hypertrophy. Diabetes 1988;37:38-43.
25. Ward KM, Mahan JD, Sherman WM. Aerobic training and diabetic nephropathy in the obese Zucker rat. Annals of Clin Lab Science 1994;24:266-277.
26. Albright AL, Mahan JD, Ward KM, Sherman WM, Roehrig K, Kirby T. Effect of aerobic training on the evolution of diabetic nephropathy in a rat model of type I diabetes. Med Sci Sports and Exercise 1995;27: 1270-1277.
27. Kitchen EL. ASCP histotechnology tech sample #3 HT-4. American Society of Pathologists 1981:1.
28. Kasiske BL, Cleary MP, O'Donnell MP, Keane WF. Effects of genetic obesity on renal structure and function in the Zucker rat. J Lab Clin Med 1985;106:598-604.
29. Bauer WC, Rosenberg BF. A quantitative study of glomerular enlargement in children with tetrology of fallot. Am J Pathol 1960;37:695-712.
30. Welible ER. Stereological methods, Vol I Point counting. New York: Academic Press 1979:101-159.
31. Fleiss JL. The design and analysis of clinical experiments. New York: John Wiley and Sons Inc. 1986:8-15.
32. Mahan JD, Sisson-Ross Sp, Vernier RL. Glomerular basement membrane anionic charge site changes in early aminonueleoside nephrosis. Am J Pathol 1986; 125:393-401.
33. Goode NP, Shires M, Crelin DM, Aparicio SR, Davidson AM. Alterations of glomerular basement membrane charge and structure in diabetic nephropathy. Diabetologia 1995;138:1455-1465.
34. Van den Born J, van Kraats AA, Bakker M, Assman K, Dikman H. Reduction of heparan sulfate-associated anionic charge sites in the glomerular basement membrane of rats with streptozocin-induced diabetic nephropathy. Diabetologia 1995;138:1169-1175.
35. Ramlee G, Coovadia L, Adhikari M. Direct and indirect tests of pore size and charge selectivity in nephrotic syndrome. J Lab Clin Med 1996;127:195-199.